MiniMed <sup> <b>™</b> </sup> 780G System Users Achieve Similar Glycemic Outcomes Regardless of Socioeconomic Disadvantage
780G system delivers consistent glycemic outcomes across socioeconomic levels, offering a promising avenue for reducing diabetes-related health disparities.
Authors
- Robert Alan Vigersky (ORCID: https://orcid.org/0000-0002-3546-3385)
- Amanda K. Kinnischtzke
- Fang Niu (ORCID: https://orcid.org/0000-0002-5035-7409)
- John Shin (ORCID: https://orcid.org/0000-0001-7831-8404)
- Toni L. Cordero (ORCID: https://orcid.org/0000-0003-4597-4194)
- JENNIFER J.F. MCVEAN (ORCID: https://orcid.org/0000-0001-8436-671X)
- Diana Miller
- NAVEEN MATHEW NATHAN SATHIYANATHAN
- VENKAT PUTCHA
- Caroline Yovanovich
- Margaret Liu
Institutions
- Medtronic (United States) (US)
Publication Details
- Journal
- Diabetes Technology & Therapeutics
- Published
- 2026-04-12
- DOI
- https://doi.org/10.1177/15209156261441462
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.00